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H2S provoked a transient but significant decrease in mean 
arterial blood pressure. H2S-induced decrease in blood 
pressure was antagonized by glibenclamide and mimicked 
by pinacidil.[1] Glibenclamide and pinacidil are specific 
KATP channel blocker and opener, respectively. Thus, 
these in vivo results indicated that the hypotensive effect 
of H2S was likely provoked by the relaxation of resistance 
blood vessels through the opening of KATP channels. Its 
mechanism of K+
ATP channel opening is still unknown, but 
it does not affect ATP concentration. K+
ATP channel activity 
is mainly responsible for insulin secretion. K+
ATP channel 
opening of β cells leads to inhibition of insulin secretion 
and channels closing leads to secretion. H2S is the gaseous 
K+ATP channel opener but it does not have channel 
specificity. So, H2S has some effect on insulin secretion. H2S 
concentration in Zuker diabetic rats was found to be high.  [5] 
INTRODUCTION
In recent years, interest has been directed toward other 
naturally occurring gases, notably H2S. Now, H2S has been 
proposed as physiological important molecule. Recently, 
high concentration of H2S has been observed in brain of 
rats, humans, and cows. The H2S concentration in rat serum 
has been found to be 46 μM[1] and in brain tissue 50-160 
μM.[2] Significant amount of H2S is produced in various 
tissues. Cystathionine gamma lyase (CSE), cystathionine β 
synthase (CBS), and 3-mercaptosulfurtransferase are the 
enzymes responsible for production of H2S.[3] The main 
subtract for these enzymes is L-cysteine. H2S is considered 
as endogenous vasorelaxant factor and cardiovascular 
function regulator.[4] Zhao showed that H2S is the first 
gaseous K+ATP channel opener.[1] Intravenous injection of 
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That means H2S is high in insulin resistance condition. 
According to Muhammed, experimental diabetes in rats 
induced by streptozotocin leads to increase expression of 
the H2S producing enzymes.  [6] H2S may have an inhibitory 
effect of insulin secretion due to nonspecific K+ATP 
channel opening activity. On the other side, H2S level is 
high in hyperinsulinemia. So, this study was carried out 
to investigate the role of H2S in insulin secretion and 
development of insulin resistance.
MATERIALS AND METHODS
Animals
Adult albino rats of either sex (Wistar strain) weighing 
between 200 and 250 g were used for the study. The animals 
were fed ad libitum with standard pellet diet and had free 
access to water. All experiments and protocols described in 
present report were approved by the Institutional Animal 
Ethics Committee (IAEC).
Experimental protocol
Effect of H2S on the K+
ATP channel of insulin secreting cell 
was studied by dividing animals into two groups. Group 
1 received NaHS 2 mg/kg i.p. (high rate of mortality 
on higher dose), and Group 2 received only saline. In 
the second experiment, animals were divided into two 
groups. Group 1 received saline only and group 2 received 
glibenclamide 10 mg/kg, p.o[7] then after NaHS 2 mg/kg 
i.p. Blood was collected from tail vein at 0, 30, 60, 120 
min after administration of drugs up to 5 h and blood 
glucose and insulin were measured. The blood glucose 
was measured by the GOD/POD[8] method and insulin 
was measured by RIA.[9]
Protocol to study the role of H2S in insulin resistance 
development
The wistar albino rats are divided into two groups (n=6). 
One group received NaHS 2 mg/kg i.p twice a day for 30 
days. Another group received only saline. The development 
of insulin resistance was studied by performing oral glucose 
tolerance test (OGTT). Also OGTT was performed 
after giving insulin by i.m. to measure sensitivity toward 
exogenous insulin. Insulin and glucose level were also 
measured before and after 30 days treatment. 
Oral Glucose Tolerance Test (OGTT)
After 30 days, 5 g/kg of glucose was administered to fasted 
animals. Blood samples were collected from tail vein under 
light anesthesia for 0 min and 15, 30, 60, 90 and 120 min 
after oral glucose administration. The blood samples were 
allowed to clot and serum was separated by centrifugation. 
The samples were measured for glucose level by the GOD/
POD method.[10] 
Oral Glucose Tolerance Test (OGTT) with Insulin
Wistar rats were divided into two groups of six animals. 
One is treated with NaHS 2 mg/kg for 30 days other 
is treated with saline. After 30 days animals were orally 
administered with 5 g/kg of glucose and insulin 1 U/kg 
i.m. Blood samples were collected from tail vein under 
light anesthesia before 0 min and 15, 30, 60, 90 and 120 
min after oral glucose administration. The samples were 
allowed to clot and serum was separated by centrifugation. 
The samples were measured for glucose level by the GOD/
POD method.[10] 
Measurement of serum H2S level in streptozotocin-
induced diabetic rat 
Type  II  diabetes  was  induced  in  wistar  rats  by   
streptozotocine.[11] After induction of diabetes, H2S 
level in serum was measured. Seventy-five microliters of 
plasma were mixed with 250 µl of 1% w/v zinc acetate 
and 425 µl distilled water. Then 20 mM N-dimethyl-p-
phenylenediamine sulfate in 7.2 mM HCl (133 µl) and 30 
mM FeCl3 in 1.2 mM HCl (133 µl) were also added to the 
test tube for 10-min incubation at room temperature. The 
protein in the plasma was removed by adding 250 µl of 
10% tricholoacetic acid to the reaction mixture and pelleted 
by centrifugation at 14 000 g (5 min). The absorbance 
of the resulting solution at 670 nm was measured with a 
spectrophotometer (TECAN Systems) in a 96-well plate. 
All samples were assayed in duplicate, and concentration 
in the solution was calculated against a calibration curve 
of NaHS (3.125–250 µM). Results show plasma H2S 
concentration in micromolar[12]
Statistical analysis
All the values were expressed as mean+SEM. The statistical 
analysis was performed using Student’s unpaired t-test and 
by AUC comparison. Value of P less than 5% (P<0.05) 
was considered statistically significant.
RESULTS
Effect of H2S on insulin and glucose level
After administration of H2S (2 mg/kg), glucose insulin 
Role of H2S in insulin resistance150   J Young Pharm Vol 2 / No 2
level were measured. Administration of H2S results in an 
increase in glucose level and a decrease in insulin level which 
became normal after 5 h [Table 1]. After administration 
of glibenclamide 10 mg/kg, p.o H2S was given. Insulin 
and glucose level in animal treated with glibenclamide and 
H2S was not significantly changed compared to saline-
treated animals. That means effect of H2S was inhibited 
by glibenclamide [Table 2].
Effect of H2S on insulin resistance
After chronic treatment with H2S, oral glucose tolerance 
test was performed to check the development of insulin 
resistance. Glucose level was measured after administration 
of glucose 5 g/kg p.o. There was no significant difference 
in glucose level compared to normal animals [Figure 1].
After chronic treatment with H2S, oral glucose tolerance 
test was performed along with administration of insulin 1 
U/kg i.m to check the development of insulin sensitivity. 
Glucose level was measured after administration of 
glucose 5 g/kg p.o. There was no significant difference 
in glucose level compared to normal animals [Figure 2]. 
Also there was no significant difference in insulin and 
glucose level before and after chronic administration of 
H2S [Table 3]. 
Table 1: Effect of H2S on glucose and insulin level 
Time 
(min)
Glucose (mg %) Insulin(µU/ml)
Saline treated H2S treated Saline treated H2S treated
0 79.9±2.7 80.1±6.1 40 ±1.9 41.3 ±1.73
30 85.9±3.6 112.3±7.1* 40.7 ±1.7 34.7±1.5*
60 89.1±5.2 142.7±8.3* 43.7±0.9 30.5 ±1.01*
120 89.6±4.1 174.7±7.3* 43.2±2.4 32.7±2.9*
180 88.7±4 164.2±8.5* 39.8 ±2 33.8 ±2.29*
240 84.4±6.3 132.8±7.9* 41.3±1.2 35 ±1.75*
300 83.8±5.1 116.6±6.9* 41 ±1.5 36.3±1.3*
Each value is mean±SEM. *P<0.05
Table 2: Effect of glibenclamide on H2S-induced 
changes on glucose and insulin level
Time 
(min)
Glucose (mg %) Insulin(µU/ml)
Saline 
treated 
group
H2S + 
glibenclamide-
treated group
Saline 
treated 
group
H2S + 
glibenclamide-
treated group
0 81.6±2.6 79.5±2.7 38 ±1.9 40 ±0.9
30 83.5±2.9 84.7±3.6 41.6 ±0.7 42.3 ±1.2
60 86.3±4.1 86.6±5.2 43±1.2 41.9±1.3
120 84.2±3.5 85.4±4.1 42.2±1.4 44.1±1.6
180 88.7±3.2 85.7±4 40 ±2 42 ± 1.5
240 85.6±4 83.2±6.3 40.7±0.8 42.7±1.2
300 87.5±3.9 83.8±5.1 40 ±1.5 42±0.8
Each value is mean±SEM, *P<0.05
Figure 1: Effect of chronic administration of H2S on oral glucose 
tolerance. Each value is mean±SEM, *P<0.05
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Figure 2: Effect of chronic administration of H2S on oral glucose 
tolerance. Each value is mean±SEM, *P<0.05
Table 3: insulin and glucose level before and after 30 
days treatment of H2S
Glucose level 
(mg %)
Insulin(µU/ml)
Before 30 days 
treatment of H2S 
82.4±1.83 42.12±0.54
After 30 days 
treatment of H2S
82.8±1.12 41.7±0.36
Each value is mean±SEM. *P<0.05
DISCUSSION
The islets of Langerhans contain four main cell types, out 
of them β cells secrete insulin. The main factor controlling 
the synthesis and secretion of insulin is the blood glucose 
concentration. ATP-sensitive K+-channel determines the 
resting membrane potential in β cells via a membrane 
transporter called Glut-2 and its subsequent metabolism 
via glycosidase and glycolysis increases intracellular ATP. 
This blocks K+
ATP causing membrane depolarization and 
opening of voltage dependant calcium channels, leading to J Young Pharm Vol 2 / No 2  151
insulin level of PPG-treated ZDF rats were significantly 
increased in comparison with that of untreated ZDF rats.[15]
CONCLUSION
From the result of our study, it can be concluded that H2S 
is pancreation K+ATP channel opener and it inhibit insulin 
secretion. High H2S level in streptozotocin-induced diabetic 
rat and ZDF rat is responsible for the low level of insulin 
and it does not have any role in development of insulin 
resistance. So, H2S can be a good target to treat diabetes 
but further detail investigation of role of H2S in insulin 
resistance is require to study.
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Ca+ signal induces insulin secretion. The insulin secretion 
is depending upon K+
ATP channel opening and closing. 
H2S is K+
ATP channel opener and it has no effect of ATP 
concentration, may be acting by direct interaction with 
protein.[13] So, it may have effect on pancreatic K+
ATP 
channel. To study the effect of H2S, NaHS was used as a 
source to release H2S in vivo. The effect of H2S on insulin 
and glucose level were studied by giving NaHS 2 mg/kg 
i.p and the blood samples were collected before and after 
NaHS administration up to 5 h. The glucose and insulin 
levels were determined in serum. The glucose level was 
significantly higher and insulin level was significantly 
lower in animals treated with the NaHS compared to 
that in the control group. According to our study, H2S 
increases glucose level and decreases insulin level and 
this effect of H2S was inhibited by glibenclamide. That 
confirms ATP-dependant K channel opening activity of 
H2S in β cells. According to Jia, H2S concentration was 
reported to be higher in Zuker diabetic rats as compared 
to that in and Zuker lean rats. Expressions of both the 
enzymes responsible for H2S production, CSE and CBS, 
were also high in streptozotocin-induced diabetic rats.[6] 
The overexpressing of these enzymes was also reported 
in patients having type II diabetes.[6] Probably H2S should 
be having some role in etiology of insulin resistance. 
So, direct study was conducted by administering H2S to 
the animals chronically and observing changes in insulin 
sensitivity. After 30 days treatment with H2S, neither 
insulin nor glucose level got altered. Glucose utilization 
was also not changed. Thus, chronic treatment of H2S for 
1 month has no significant effects on insulin sensitivity. 
H2S level was also high in streptozotocin-induced diabetic 
rats compared to saline-treated rats. High level of H2S is 
because of overexpression of H2S forming enzymes.[6] So, 
H2S is not responsible for development of diabetes, but 
high H2S level in diabetes is due to overexpression of H2S 
producing enzyme. This over expression of enzymes is may 
be due to metabolic disturbance in diabetes. A characteristic 
of streptozotocin-induced diabetes is strong reduction of 
the pancreatic insulin stores, decreased basal insulin levels, 
and lack of plasma insulin response to glucose in vivo.[14] 
This decrease in insulin level and lack of plasma insulin 
response to glucose may be due to high H2S level in these 
diabetic animals. Also in Zuker diabetic fatty rats insulin 
level is low, it may be due to high level of H2S. During 
OGTT, the increase in serum insulin level of Zuker diabetic 
fatty (ZDF) rats was delayed with much lower amplitude 
as compared with that of ZL rats. Treatment with H2S 
producing enzyme inhibitor, DL-propargylglycine (PPG), 
elevates the basal level of serum insulin of ZDF rats. Both 
the rate of increase and the peak amplitude of serum 
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